Clinical Trial

Serotonin Receptor Blockers in Ischemic Mitral Regurgitation

Name: Serotonin Receptor Blockers in Ischemic Mitral Regurgitation — clinical trial record (NCT05469165)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CYPRO-MR

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is intended to investigate the effect of cyproheptadine (a 5HT2B receptor blocker) on mitral regurgitation severity.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2022-07-19.

Status change: Not Yet Recruiting → Recruiting 2023-11-13

Trial Details

NCT Number	NCT05469165
Lead Sponsor	Laval University Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions	Ischemic Mitral Regurgitation
Enrollment	214 participants
Start Date	2023-06-20
Primary Completion	2026-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2023-11-15